CytoMed Therapeutics Ltd banner

Multiples-Based Value

The Multiples-Based Value for CytoMed Therapeutics Ltd (F98) under the Base Case is 0.22 EUR. Compared with the current market price of 0.73 EUR, the stock appears Overvalued by 70% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

F98 Multiples-Based Value
Base Case
€0.22
Overvaluation 70%
Multiples-Based Value
Price €0.73
C

Multiples Across Competitors

F98 Competitors Multiples
CytoMed Therapeutics Ltd Competitors